Synapsoft logo
AI Insights from Disclosures
Searching...
SillaJen, Inc. 215600
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
SillaJen, Inc. is a biotech venture company established in March 2006 to develop new anticancer drugs. The anticancer agent currently under development is an oncolytic virus (OV): a genetically recombined anticancer virus that selectively infects only cancer cells without harming normal cells in the body, destroys the infected cancer cells, and at the same time awakens the body's immune system so that it is induced to treat the cancer on its own.
Representative Director Park Sanggeun, Han Sanggyu
Founded March 28, 2006
Corporation Type KOSDAQ
Industry Classification Research and experimental development on medical sciences and pharmacy
Corporate number 18011-0550194
Business number 603-81-61936
Phone Number 02-368-2600
Fax Number 027837555
Company Address 106 Cheonggyecheon-ro, Jung-gu, Seoul
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant